AngioScore has begun patient enrollment in a first-in-human (FIH) study of its CardioSculpt Valvuloplasty Scoring Balloon catheter, designed to treat patients with symptomatic critical aortic valve stenosis. CardioSculpt catheter, which ...
Tags: CardioSculpt Valvuloplasty Scoring Balloon catheter, catheter
TissueGene has completed enrolling patients in a US-based Phase II trial of its TG-C therapy, designed to treat patients with Grade 3 chronic degenerative joint disease (DJD) of the knee. Comprising human allogeneic chondrocytes, the TG-C ...
Tags: TG-C therapy, therapeutic protein, TG-C
C. R. Bard's Lutonix technology center has completed enrolling patients in its pivotal investigational device exemption (IDE) LEVANT 2 trial, designed to evaluate Lutonix drug coated PTA dilatation catheter (DCB) as a treatment for ...
Tags: pivotal investigational device, drug coated PTA dilatation catheter
Allegro Diagnostics has completed patient enrollment in 1,320-patient Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer II (AEGIS II) trial for BronchoGen genomic test. BronchoGen, which is built on the company's ...
Tags: clinical trial, clinical research, lung cancer molecular diagnostic
Spinal Restoration has completed enrolling patients in its Phase III Investigational new drug (IND) study of the Biostat System. The Biostat System, which comprises a human derived, resorbable Biostat Biologx Fibrin Sealant, features the ...
Tags: Spinal Restoration, IND study, Biostat System, study success
Pharmaceutical and diagnostic company Prometheus Laboratories has granted an oncology programme to Clinipace Worldwide, a global digital research organization (dCRO). As part of the contract, Clinipace Worldwide will study Proleukin ...
Tags: medical research, data management platform, clinical trial
Galena Biopharma has reported a net loss of $6.26m, or $0.09 per share, for the third quarter ended 30 September 2012 compared to a net loss of $5.47m, or $0.09 per share, for the third quarter ended 30 September 2011. Operating loss for ...
Tags: Net Loss, operational and business development, patient enrollment
Ophthalmologic products provider, InSite Vision has started the patient enrollment for the first Phase 3 clinical trial of BromSite (ISV-303), which is used to reduce pain and inflammation post cataract surgery. The study will enroll ...
Tags: Insite Vision, BromSite Phase 3 Study, Ophthalmologic products
Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...
Cohera Medical has completed enrolling patients in a US clinical study of its internal TissuGlu surgical adhesive. TissuGlu, which adheres the tissue flap created during the procedure, is designed to help eliminate fluid accumulation and ...
Brainsway has started the multicenter clinical trial of its Deep TMS device, designed to treat various neurological and psychopathological disorders. Noninvasive Deep TMS device has also the potential to treat schizophrenia, obesity, ...
Tags: Brainsway, Deep TMS device, Parkinson's disease, Alzheimer's disease
Conventus Orthopaedic has completed patient enrollment in a clinical study of its Conventus DRS Implant. The minimally invasive implant uses Conventus DRS technology to stabilize the fractured bone fragments from within the bone and treat ...
Tags: Conventus DRS Implant, fractured bone fragments, clinical study
Benvenue Medical has completed enrolling patients in its Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial (KAST). Kiva system, which features a proprietary flexible Kiva implant, is designed to reduce ...
Tags: Kiva System, Safety and Effectiveness Trial, FDA, KAST Study
Terumo Interventional Systems has completed enrolling patients in its Occlusive/Stenotic Peripheral Artery REvascularization StudY (OSPREY). The MISAGO stent comprises a nitinol stent pre-mounted on the distal portion of a rapid-exchange ...
Tags: OSPREY Trial, Misago Stent system, superficial femoral artery